Difference between revisions of "Part:BBa K3806008"
Line 18: Line 18:
  
  
−
[[File:T--TUDelft--Aptazyme.png|1000px|center|<b>Fig. 1 Structure of aptazyme (left). 3D structure prediction of aptazyme (right) ]]
+
[[File:T--TUDelft--Aptazyme.png|800px|center|<b>Fig. 1 Structure of aptazyme (left). 3D structure prediction of aptazyme (right) ]]
  
  

Revision as of 16:34, 20 October 2021


Theophylline-binding aptazyme

Positive control for DRIVER

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Usage and Biology

Ligand-dependent self-cleaving ribozymes, also known as aptazymes, have emerged in recent years as valuable tools to control gene expression. Aptazymes can be programmed to respond to a wide range of small-molecule ligands with high sensitivity and selectivity. They therefore have a large number of potential applications, ranging from disease diagnosis, prognosis, or treatment to detecting small pollutants in the environment. Synthetic genetic switches are a promising tool to detect and quantify small molecules. Ligand regulated self-cleaving ribozymes are of special interest as cleavage of the aptazyme can be coupled to regulated gene expression in vivo or in vitro. Moreover, newly developed methods such as DRIVER (de novo rapid in vitro evolution of RNA biosensors) enable rapid, automated, and multiplexed engineering of aptazymes sequences to diverse ligands.

Aptazymes are a class of engineered riboswitches that control gene expression by small molecule-induced self-cleavage of a ribozyme

The study of Townshed et al. [1] created a theophylline binding aptazyme that is evolved to undergo self-cleavage in the absence of theophylline and preserves its structure in the presence of theophylline. The TU Delft 2021 team characterized the cleavage of this aptazyme on an Urea-PAGE gel. This part is extensively used in the engineering of vitamin binding aptazymes as control for each DRIVER round.

The TU Delft 2021 team provides the iGEM community with a novel genetic switch construct (BBa_K3806016) in which an aptazyme sequence is fused to the lacZ reporter gene for converting ligand concentration to a colorimetric read-out. The BBa_K3806016 contains a theophylline-binding aptazyme sequence [1], yet this part is designed to be modular and serve as a template to engineer other ligand-specific genetic circuits.


Fig. 1 Structure of aptazyme (left). 3D structure prediction of aptazyme (right)


References

  1. Townshend, B., Xiang, J. S., Manzanarez, G., Hayden, E. J. and Smolke, C. (2021). A multiplexed, automated evolution pipeline enables scalable discovery and characterization of biosensors. Nat Commun, 12, 1437.